Virazole

— THERAPEUTIC CATEGORIES —
  • Viral infections

Virazole Generic Name & Formulations

General Description

Ribavirin 6g/vial; pwd for reconstitution and aerosol inhalation.

Pharmacological Class

Nucleoside analogue.

How Supplied

Vials—4

Virazole Indications

Indications

Severe lower respiratory infections due to respiratory syncytial virus in hospitalized infants and young children.

Virazole Dosage and Administration

Adult

Not recommended.

Children

Begin treatment preferably within first 3 days of infection. 20mg/mL as starting solution in drug reservoir for continuous aerosol administration for 12–18 hours per day for 3–7 days.

Virazole Contraindications

Contraindications

Pregnancy (Cat.X).

Virazole Boxed Warnings

Boxed Warning

Should be undertaken only by experienced physicians and support staff. Sudden deterioration of respiratory function in infants. Not indicated for use in adults.

Virazole Warnings/Precautions

Warnings/Precautions

See full labeling. Monitor respiratory function, fluid status. Discontinue if sudden deterioration of respiratory function. Use with mechanical ventilators should be undertaken only by physicians and support staff familiar with this mode of administration. Drug may precipitate in mechanical ventilator, causing dysfunction. Avoid unnecessary occupational exposure. Nursing mothers.

Virazole Pharmacokinetics

See Literature

Virazole Interactions

Interactions

Monitor digitalis.

Virazole Adverse Reactions

Adverse Reactions

Pulmonary function deterioration, bronchospasm, pulmonary edema, hypoventilation, bacterial pneumonia, pneumothorax, apnea, ventilator dependence, atelectasis, cardiac arrest, hypotension, reticulocytosis, hemolytic anemia, rash, conjunctivitis.

Virazole Clinical Trials

See Literature

Virazole Note

Not Applicable

Virazole Patient Counseling

See Literature